![Tracey Sacco](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tracey Sacco
Keine laufenden Positionen mehr
Vermögen: 4 Mio $ am 31.05.2026
Profil
Tracey Sacco worked at Acceleron Pharma, Inc. from 2012 to 2021 as SVP-Global Marketing & Alliance Management.
Ms. Sacco worked at Scholar Rock Holding Corp.
from 2023 to 2025 as Chief Commercial Officer.
Ms. Sacco completed undergraduate studies at Boston College and earned an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.04.2025 | 71 750 ( 0,06 % ) | 4 Mio $ | 31.05.2026 |
Ehemalige bekannte Positionen von Tracey Sacco
| Unternehmen | Position | Ende |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Corporate Officer/Principal | 01.06.2025 |
| ACCELERON PHARMA INC. | Vertrieb & Marketing | 01.09.2021 |
Ausbildung von Tracey Sacco
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
